WISE enrolls first patient in clinical study of novel neuro-electrodes for brain monitoring

WISE Srl, a medical device company developing next-generation implantable leads for neuromonitoring and neuromodulation, has enrolled its first patient in the
pivotal clinical study of its WISE Cortical Strip. The WISE Cortical Strip is a single use medical device for IntraOperative Neurophysiological Monitoring during brain tumour and epilepsy surgeries. It is used for continuous recording of the brain’s electrical activity and for brain stimulation.

The WIN Study (WISE Cortical Strip for Intraoperative Neurophysiological Monitoring study) is a prospective, interventional, multi-center, open-label premarket study, expected to enroll approximately 33 patients. Designed to confirm the safety and performance of the WISE Cortical Strip, the first patient has been enrolled at Universitätsspital Zürich. The study is due to conclude in Q3 2019, with the results to be published shortly afterwards.

Read more in the official press release here.